Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma

Haematologica

Volumn 92, Issue 10, 2007, Pages 1419-1422

  Anderson, Patricia J ^a   Gailani, David ^b   Feys, Hendrik B ^c   Gao, Weiqiang ^a   Majerus, Elaine M ^a   Vanhoorelbeke, Karen ^c   Sadler, J Evan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

ADAMTS13; Factor XI; Von Willebrand Factor

Indexed keywords

BLOOD CLOTTING FACTOR 9; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL FILTRATION; HEMOSTASIS; HUMAN; IMMUNOPRECIPITATION; PROTEIN FUNCTION; PROTEIN INTERACTION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; CHROMATOGRAPHY, GEL; FACTOR XI; HUMANS; PROTEIN BINDING;

EID: 36348993732     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11478     Document Type: Article

References (18)

1. Tsai HM. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med 2006;57:419-36.
2. Sadler JE. Thrombotic thrombocytopenic purpura: a moving target. Hematology Am Soc Hematol Educ Program 2006:415-20.
3. Dong JF. Structural and functional correlation of ADAMTS13. Curr Opin Hematol 2007;14:270-6.
4. Miyata T, Kokame K, Banno F, Shin Y, Akiyama M. ADAMTS13 assays and ADAMTS13-deficient mice. Curr Opin Hematol 2007;14:277-83.
5. Starke R, Machin S, Scully M, Purdy G, Mackie I. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura. Br J Haematol 2007;136:649-55.
6. Veyradier A, Girma JP. Assays of ADAMTS-13 activity. Semin Hematol 2004;41:41-7.
7. Veyradier A, Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Haemost 2005; 3:2420-7.
8. Majerus EM, Anderson PJ, Sadler JE. Binding of ADAMTS13 to von Willebrand factor. J Biol Chem 2005; 280:21773-8.
9. Anderson PJ, Kokame K, Sadler JE. Zinc and calcium ions cooperatively modulate ADAMTS13 activity. J Biol Chem 2006;281:850-7.
10. Sun M-F, Zhao M, Gailani D. Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX. J Biol Chem 1999;274:36373-8.
11. Feys HB, Liu F, Dong N. ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. J Thromb Haemost 2006; 4:955-62.
12. Purvis AR, Sadler JE. A covalent oxidoreductase intermediate in propeptide-dependent von Willebrand factor multimerization. J Biol Chem 2004; 279:49982-8.
13. Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004; 103:4043-9.
14. Gerritsen HE, Robles R, Lammle B, Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood 2001; 98:1654-61.
15. Zheng X, Nishio K, Majerus EM, Sadler JE. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13. J Biol Chem 2003; 278: 30136-41.
16. Bouma BN, Griffin JH. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem 1977;252:6432-7.
17. Ackers GK. A new calibration procedure for gel filtration columns. J Biol Chem 1967;242:3237-8.
18. Sinha D, Marcinkiewicz M, Gailani D, Walsh PN. Molecular cloning and biochemical characterization of rabbit factor XI. Biochem J 2002;367:49-56.